Condition
Malignant Mesothelioma
Estimated Enrollment: 153
Age Group: 18 Years to 69 Years (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: SAKK 17/04|SWS-SAKK-17/04|EU-20615|2006-000445-19|LILLY-SAKK-17/04|CDR0000481153
Study First Received: June 7, 2006
Last Updated: March 10, 2015
Estimated Primary Completion Date: December 2013
Primary Outcome Measures:
Complete macroscopic resection (part 1)|Loco-regional relapse-free survival (part 2)|Response to neoadjuvant therapy (part 1)|Adverse drug reaction to neoadjuvant therapy (part 1)|Operability (part 1)|Surgical complications (part 1)|Reasons for non-randomization (part 1)|Relapse-free or progression-free survival (part 1)|Adverse reaction to postoperative radiotherapy (part 2)|Late toxicity (part 2)|Feasibility of postoperative radiotherapy (part 2)|Relapse-free survival (part 2)|Psychological distress (quality of life) (part 2)|Overall survival
Sponsors and Collaborators:
Swiss Group for Clinical Cancer Research
Website Link: https://ClinicalTrials.gov/show/NCT00334594
